PHIO PHARMACEUTICALS CORP (PHIO) Stock Price, Quote, News and Overview
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
PHIO Quote, Performance and Key Statistics
PHIO PHARMACEUTICALS CORP
NASDAQ:PHIO (2/4/2025, 8:01:12 PM)
Premarket: 2.01 -0.03 (-1.47%)2.04
0 (0%)
The current stock price of PHIO is 2.04 USD. In the past month the price increased by 3.55%. In the past year, price decreased by -61.48%.
PHIO Latest News, Press Releases and Analysis
These stocks have an unusual volume in today's session
In today's session, these stocks are experiencing unusual volume.
Top movers in Thursday's session
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Top movers in Wednesday's session
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Which stocks are gapping on Wednesday?
Let's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run
Around 34% foresee a pullback, while 13% are uncertain due to the stock's volatility.
PHIO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.77 | 335.67B | ||
| AMGN | AMGEN INC | 14.58 | 155.36B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 945.65 | 124.20B | ||
| GILD | GILEAD SCIENCES INC | 22.12 | 122.12B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.27 | 76.60B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.95B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.08B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.76B | ||
| NTRA | NATERA INC | N/A | 23.00B | ||
| BIIB | BIOGEN INC | 8.73 | 20.76B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.52 | 15.78B |
Related stock screener links
About PHIO
Company Profile
Phio Pharmaceuticals Corp is a US-based company operating in Biotechnology industry. The company is headquartered in Marlborough, Massachusetts and currently employs 8 full-time employees. The company went IPO on 2012-05-10. Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The firm's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The company is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. The firm's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.
Company Info
PHIO PHARMACEUTICALS CORP
11 Apex Drive, Suite 300A, Pmb 2006
Marlborough MASSACHUSETTS 01752 US
CEO: Gerrit Dispersyn
Employees: 9
Company Website: https://phiopharma.com/
Investor Relations: http://investors.phiopharma.com/investor-relations
Phone: 15087673861
PHIO FAQ
What is the stock price of PHIO?
The current stock price of PHIO is 2.04 USD.
What is the symbol for PHIO PHARMACEUTICALS CORP stock?
The exchange symbol of PHIO PHARMACEUTICALS CORP is PHIO and it is listed on the Nasdaq exchange.
On which exchange is PHIO stock listed?
PHIO stock is listed on the Nasdaq exchange.
Is PHIO a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PHIO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PHIO.
Does PHIO stock pay dividends?
PHIO does not pay a dividend.
What is the Price/Earnings (PE) ratio of PHIO?
PHIO does not have a PE ratio as the earnings reported over the last twelve months were negative (-13.28).
What is the Short Interest ratio of PHIO stock?
The outstanding short interest for PHIO is 33.71% of its float.
PHIO Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to PHIO. When comparing the yearly performance of all stocks, PHIO is a bad performer in the overall market: 95.15% of all stocks are doing better.
PHIO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PHIO. While PHIO has a great health rating, there are worries on its profitability.
PHIO Financial Highlights
Over the last trailing twelve months PHIO reported a non-GAAP Earnings per Share(EPS) of -13.28. The EPS increased by 12.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -126.5% | ||
| ROE | -150% | ||
| Debt/Equity | 0 |
PHIO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PHIO. The Buy consensus is the average rating of analysts ratings from 7 analysts.